Abstract
Nitric oxide (NO.) and its reaction products are key players in the physiology and pathophysiology of inflammatory settings such as sepsis and shock. The consequences of the expression of inducible NO. synthase (iNOS, NOS-2) can be either protective or damaging to the liver. We have delineated two distinct hepatoprotective actions of NO.: the stimulation of cyclic guanosine monophosphate and the inhibition of caspases by S-nitrosation. In contrast, iNOS / NO. promotes hepatocyte death under conditions of severe redox stress, such as hemorrhagic shock or ischemia / reperfusion. Redox stress activates an unknown molecular switch that transforms NO., which is hepatoprotective under resting conditions, into an agent that induces hepatocyte death. We hypothesize that the magnitude of the redox stress is a major determinant for the effects of NO. on cell survival by controlling the chemical fate of NO.. To address this hypothesis, we have carried out studies in relevant in vivo and in vitro settings. Moreover, we have constructed an initial mathematical model of caspase activation and coupled it to a model describing some of the reactions of NO • in hepatocytes. Our studies suggest that modulation of iron, oxygen, and superoxide may dictate whether NO. is hepatoprotective or hepatotoxic.
Keywords: inflammatory inos, isoform, gene transcription, cytokines, apoptosis, rodent models, inflammation
Current Molecular Medicine
Title: Inflammatory Modulation of Hepatocyte Apoptosis by Nitric Oxide: In Vivo, In Vitro, and In Silico Studies
Volume: 4 Issue: 7
Author(s): Yoram Vodovotz, Peter K. M. Kim, Elife Zerrin Bagci, G. Bard Ermentrout, Carson C. Chow, Ivet Bahar and Timothy R. Billiar
Affiliation:
Keywords: inflammatory inos, isoform, gene transcription, cytokines, apoptosis, rodent models, inflammation
Abstract: Nitric oxide (NO.) and its reaction products are key players in the physiology and pathophysiology of inflammatory settings such as sepsis and shock. The consequences of the expression of inducible NO. synthase (iNOS, NOS-2) can be either protective or damaging to the liver. We have delineated two distinct hepatoprotective actions of NO.: the stimulation of cyclic guanosine monophosphate and the inhibition of caspases by S-nitrosation. In contrast, iNOS / NO. promotes hepatocyte death under conditions of severe redox stress, such as hemorrhagic shock or ischemia / reperfusion. Redox stress activates an unknown molecular switch that transforms NO., which is hepatoprotective under resting conditions, into an agent that induces hepatocyte death. We hypothesize that the magnitude of the redox stress is a major determinant for the effects of NO. on cell survival by controlling the chemical fate of NO.. To address this hypothesis, we have carried out studies in relevant in vivo and in vitro settings. Moreover, we have constructed an initial mathematical model of caspase activation and coupled it to a model describing some of the reactions of NO • in hepatocytes. Our studies suggest that modulation of iron, oxygen, and superoxide may dictate whether NO. is hepatoprotective or hepatotoxic.
Export Options
About this article
Cite this article as:
Vodovotz Yoram, Kim K. M. Peter, Bagci Zerrin Elife, Ermentrout Bard G., Chow C. Carson, Bahar Ivet and Billiar R. Timothy, Inflammatory Modulation of Hepatocyte Apoptosis by Nitric Oxide: In Vivo, In Vitro, and In Silico Studies, Current Molecular Medicine 2004; 4 (7) . https://dx.doi.org/10.2174/1566524043359944
DOI https://dx.doi.org/10.2174/1566524043359944 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sex Hormones, Metabolic Syndrome and Kidney
Current Topics in Medicinal Chemistry Role of NADPH Oxidase in Hypertension and Diabetic Nephropathy
Current Hypertension Reviews Molecular Recognition Mechanisms for Detecting Cell Death In Vivo
Current Pharmaceutical Biotechnology Roles of SUMOylation in Heart Development and Cardiovascular Diseases
Current Molecular Medicine Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Amelioration of Myocardial Ischemic Reperfusion Injury with Calendula Officinalis
Current Pharmaceutical Biotechnology The Chemical Biology of Immunophilin Ligands
Current Medicinal Chemistry A Review of Intracoronary Abciximab in Percutaneous Coronary Interventions- where are we now and where do we go from here?
Recent Patents on Cardiovascular Drug Discovery Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Pharmacological Pre- and Post- Conditioning Agents: Reperfusion-Injury of the Heart Revisited
Mini-Reviews in Medicinal Chemistry Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy Aging is Neuroprotective During Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons
Current Neurovascular Research Interaction of Chemokines with their Receptors - From Initial Chemokine Binding to Receptor Activating Steps
Current Medicinal Chemistry Effects of Coenzyme Q and Creatine Supplementation on Brain Energy Metabolism in Rats Exposed to Chronic Cerebral Hypoperfusion
Current Alzheimer Research Myocardial Cellular Damage and Antioxidant Status in Off-Pump Versus On-Pump Coronary Artery Bypass Grafting - A Prospective Study
Vascular Disease Prevention (Discontinued) Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Current Drug Metabolism Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Introduction from the Guest Editor: The Many Facets of Heme Oxygenase
Current Neurovascular Research PAI-1 Antagonists: Predictable Indications and Unconventional Applications
Current Drug Targets Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology